Inflammation in obsessive-compulsive disorder: A literature review and hypothesis-based potential of transcranial photobiomodulation
- PMID: 38459770
- DOI: 10.1002/jnr.25317
Inflammation in obsessive-compulsive disorder: A literature review and hypothesis-based potential of transcranial photobiomodulation
Abstract
Obsessive-compulsive disorder (OCD) is a disabling neuropsychiatric disorder that affects about 2%-3% of the global population. Despite the availability of several treatments, many patients with OCD do not respond adequately, highlighting the need for new therapeutic approaches. Recent studies have associated various inflammatory processes with the pathogenesis of OCD, including alterations in peripheral immune cells, alterations in cytokine levels, and neuroinflammation. These findings suggest that inflammation could be a promising target for intervention. Transcranial photobiomodulation (t-PBM) with near-infrared light is a noninvasive neuromodulation technique that has shown potential for several neuropsychiatric disorders. However, its efficacy in OCD remains to be fully explored. This study aimed to review the literature on inflammation in OCD, detailing associations with T-cell populations, monocytes, NLRP3 inflammasome components, microglial activation, and elevated proinflammatory cytokines such as TNF-α, CRP, IL-1β, and IL-6. We also examined the hypothesis-based potential of t-PBM in targeting these inflammatory pathways of OCD, focusing on mechanisms such as modulation of oxidative stress, regulation of immune cell function, reduction of proinflammatory cytokine levels, deactivation of neurotoxic microglia, and upregulation of BDNF gene expression. Our review suggests that t-PBM could be a promising, noninvasive intervention for OCD, with the potential to modulate underlying inflammatory processes. Future research should focus on randomized clinical trials to assess t-PBM's efficacy and optimal treatment parameters in OCD. Biomarker analyses and neuroimaging studies will be important in understanding the relationship between inflammatory modulation and OCD symptom improvement following t-PBM sessions.
Keywords: inflammation; low-level light therapy; obsessive-compulsive disorder; transcranial photobiomodulation.
© 2024 Wiley Periodicals LLC.
References
REFERENCES
-
- Adams, T. G., Cisler, J. M., Kelmendi, B., George, J. R., Kichuk, S. A., Averill, C. L., Anticevic, A., Abdallah, C. G., & Pittenger, C. (2022). Transcranial direct current stimulation targeting the medial prefrontal cortex modulates functional connectivity and enhances safety learning in obsessive-compulsive disorder: Results from two pilot studies. Depression and Anxiety, 39(1), 37-48. https://doi.org/10.1002/da.23212
-
- Ahrabi, B., Mirakabad, T., Sadat, F., Niknazar, S., Payvandi, A. A., Roozbahany, A., Navid, A., Mahnaz, T., Dordshaikh, S., & Abbaszadeh, H. A. (2022). Photobiomodulation therapy and cell therapy improved Parkinson's diseases by neuro-regeneration and tremor inhibition. Journal of Lasers in Medical Sciences, 13, e28. https://doi.org/10.34172/jlms.2022.28
-
- Ai, Y.-W., Du, Y., Chen, L., Liu, S.-H., Liu, Q.-S., & Cheng, Y. (2023). Brain inflammatory marker abnormalities in major psychiatric diseases: A systematic review of postmortem brain studies. Molecular Neurobiology, 60(4), 2116-2134. https://doi.org/10.1007/s12035-022-03199-2
-
- Alonso, P., López-Solà, C., Real, E., Segalàs, C., & Menchón, J. M. (2015). Animal models of obsessive-compulsive disorder: Utility and limitations. Neuropsychiatric Disease and Treatment, 11, 1939-1955. https://doi.org/10.2147/NDT.S62785
-
- Askalsky, P., & Iosifescu, D. V. (2019). Transcranial photobiomodulation for the management of depression: Current perspectives. Neuropsychiatric Disease and Treatment, 15, 3255-3272. https://doi.org/10.2147/NDT.S188906
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
